These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6840161)

  • 21. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemorheologic effects of vasodilation in essential hypertension.
    Wysocki M; Andersson OK; Persson B; Bagge U; Braide M
    Angiology; 1996 Sep; 47(9):869-78. PubMed ID: 8810653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effect of prizidilol.
    Jounela AJ; Honkala M; Huikuri H
    Ann Clin Res; 1984; 16(3):176-80. PubMed ID: 6383185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cadralazine in a large group of hypertensive patients chronically treated with cadralazine: advantage over a conventional study in a small group of patients.
    Lecaillon JB; Dubois JP; Darragon T; Motolese M; Racine A; Ducret F; Grouberman D; Cordonnier D; Chanard J; Glorioso M
    Ther Drug Monit; 1991 Mar; 13(2):103-8. PubMed ID: 2053115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
    Dorigotti L; Ferni G; Lombroso M; Semeraro C
    Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cadralazine on brachial artery hemodynamics and forearm venous tone in essential hypertension.
    Bouthier JA; Safar ME; Curien ND; London GM; Levenson JA; Simon AC
    Clin Pharmacol Ther; 1986 Jan; 39(1):82-8. PubMed ID: 2935350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect of cilazapril in essential hypertensive patients. Clinical study with 24 h ambulatory blood pressure monitoring.
    Hiwatari M; Abe K; Yoshinaga K; Saito T
    Arzneimittelforschung; 1991 Nov; 41(11):1137-40. PubMed ID: 1839765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of cilazapril, 2.5 and 5 mg, once daily versus placebo on ambulatory blood pressure following single- and repeat-dose administration.
    Lacourcière Y; Poirier L; Provencher P; Pyzyk M
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):219-23. PubMed ID: 1717782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers.
    Fox JS; Whitehead EM; Shanks RG
    Br J Clin Pharmacol; 1991 Jul; 32(1):45-9. PubMed ID: 1888641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
    Salzmann R; Gerber W; Pally C; Scholtysik G
    J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-effect relationship of rilmenidine after chronic administration.
    Luccioni R; Lambert M; Ambrosi P; Scemama M
    Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG; Bolli P; Lee C
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.
    Thibonnier M; Bonnet F; Corvol P
    Eur J Clin Pharmacol; 1980; 17(3):161-4. PubMed ID: 6988222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I; Terhaag B; Wierich W; Herrmann WM
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous endralazine in essential hypertension.
    Hoffmann JJ; Thien T; van T'Laar A
    Br J Clin Pharmacol; 1983 Jul; 16(1):39-44. PubMed ID: 6349669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O; Kushida H; Kunihara M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and clinical effects of ISF 2123, a new antihypertensive agent.
    Pellegrini R; Abbondati G
    Farmaco Prat; 1977 Jan; 32(1):19-24. PubMed ID: 838036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.